WHOOP has crossed the $10 billion threshold, closing a $575 million Series G round that values the company at $10.1 billion—nearly triple its previous $3.6 billion mark. The investor base reflects a deliberate positioning at the intersection of performance, healthcare, and capital: the round was led by Collaborative Fund, with participation from sovereign wealth funds, medical institutions, and a roster of high-profile athletes. Backers include the Qatar Investment Authority, Mubadala Investment Company, Abbott Laboratories, the Mayo Clinic, and GP Bullhound, alongside investors such as Cristiano Ronaldo, LeBron James, and Rory McIlroy. The signal is clear: WHOOP is no longer being valued purely as a consumer hardware company, but as a broader performance platform with relevance across sport, health, and data.
The fundamentals support that shift. The company now reports more than 2.5 million members globally, a bookings run rate of $1.1 billion at the end of 2025—up 103% year-on-year—and positive operating cash flow. Its model remains intentionally narrow: a screenless, wrist-worn band paired with a subscription service that tracks sleep, recovery, strain, and cardiovascular metrics continuously, without the distraction layer of notifications or general-purpose smartwatch features. That focus has proven durable. Entry pricing starts at $149 for the first year, rising to $199 on renewal—positioning the product less as a device purchase and more as an ongoing service.
The new capital is set to fund international expansion across Europe, the Gulf, Latin America, and Asia, with an IPO expected within the next one to two years. In a crowded wearable market, WHOOP’s differentiation has been restraint—fewer features, tighter positioning, and a clearer definition of value. At $10 billion, that strategy is now being priced accordingly. Visit.
